Alliin, a garlic (Allium sativum) compound, prevents LPS-induced inflammation in 3T3-L1 adipocytes

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Quintero Fabián, Saray ^a   Ortuño Sahagún, Daniel ^a   Vázquez Carrera, Manuel ^b   López Roa, Rocío Ivette ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALLIIN; EARLY GROWTH RESPONSE FACTOR 1; GLUCOSE; INSULIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; URIC ACID; ANTIINFLAMMATORY AGENT; CCL2 PROTEIN, MOUSE; CYSTEINE; DRUG DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTOME;

ADIPOCYTE; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GARLIC; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HEART PROTECTION; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; URIC ACID BLOOD LEVEL; WESTERN BLOTTING; 3T3 CELL LINE; ANIMAL; DRUG ANTAGONISM; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; ANTI-INFLAMMATORY AGENTS; CHEMOKINE CCL2; CYSTEINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICE; NF-KAPPA B; PHOSPHORYLATION; TRANSCRIPTOME;

EID: 84896326331     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/381815     Document Type: Article

References (57)

1. Kawada T., Takahashi N., Fushiki T., Biochemical and physiological characteristics of fat cell. Journal of Nutritional Science and Vitaminology 2001 47 1 1 12 2-s2.0-0035107753 (Pubitemid 32225216)
2. de Heredia F. P., Gómez-Martínez S., Marcos A., Obesity, inflammation and the immune system. Proceedings of the Nutrition Society 2012 71 2 332 338 10.1017/S0029665112000092
3. Kershaw E. E., Flier J. S., Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism 2004 89 6 2548 2556 2-s2.0-2942650969 10.1210/jc.2004-0395 (Pubitemid 38766330)
4. Trayhurn P., Wood I. S., Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochemical Society Transactions 2005 33 5 1078 1081 2-s2.0-27844545767 10.1042/BST20051078 (Pubitemid 41659117)
5. Ferrante A. W. Jr., Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. Journal of Internal Medicine 2007 262 4 408 414 2-s2.0-34548639473 10.1111/j.1365-2796.2007.01852.x (Pubitemid 47404372)
6. Cani P. D., Amar J., Iglesias M. A., Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007 56 7 1761 1772 10.2337/db06-1491 (Pubitemid 47025442)
7. Lumeng C. N., Bodzin J. L., Saltiel A. R., Obesity induces a phenotypic switch in adipose tissue macrophage polarization. Journal of Clinical Investigation 2007 117 1 175 184 2-s2.0-33846026712 10.1172/JCI29881 (Pubitemid 46048464)
8. Osborn O., Olefsky J. M., The cellular and signaling networks linking the immune system and metabolism in disease. Nature Medicine 2012 18 3 363 374 2-s2.0-84857985148 10.1038/nm.2627
9. Kim M. S., Lee M. S., Kown D. Y., Inflammation-mediated obesity and insulin resistance as targets for nutraceuticals. Annals of the New York Academy of Sciences 2011 1229 1 140 146 2-s2.0-79960779324 10.1111/j.1749-6632.2011. 06098.x
10. Iciek M., Kwiecień I., Włodek L., Biological properties of garlic and garlic-derived organosulfur compounds. Environmental and Molecular Mutagenesis 2009 50 3 247 265 2-s2.0-63049130448 10.1002/em.20474
11. Rose P., Whiteman M., Moore P. K., Yi Z. Z., Bioactive S-alk(en)yl cysteine sulfoxide metabolites in the genus Allium: the chemistry of potential therapeutic agents. Natural Product Reports 2005 22 3 351 368 2-s2.0-21244434921 10.1039/b417639c (Pubitemid 40885716)
12. Gu X., Zhu Y. Z., Therapeutic applications of organosulfur compounds as novel hydrogen sulfide donors and/or mediators. Expert Review of Clinical Pharmacology 2011 4 1 123 133 2-s2.0-78650438090 10.1586/ecp.10.129
13. Ariga T., Seki T., Antithrombotic and anticancer effects of garlic-derived sulfur compounds: a review. BioFactors 2006 26 2 93 103 2-s2.0-33745541339 10.1002/biof.5520260201 (Pubitemid 43979362)
14. Ide N., Lau B. H. S., Garlic compounds minimize intracellular oxidative stress and inhibit nuclear factor- B activation. Journal of Nutrition 2001 131 3 1020S 1026S 2-s2.0-0035126519 (Pubitemid 32195001)
15. Dirsch V. M., Kiemer A. K., Wagner H., Vollmar A. M., Effect of allicin and ajoene, two compounds of garlic, on inducible nitric oxide synthase. Atherosclerosis 1998 139 2 333 339 2-s2.0-0031830565 10.1016/S0021-9150(98) 00094-X (Pubitemid 28361818)
16. Stoll A., Seebeck E., Über Alliin, die genuine Muttersubstanz des Knoblauchöls. Experientia 1947 3 3 114 115 2-s2.0-34250567147 10.1007/BF02137698
17. Sakurai H., Tsuchimoto N., Fukumoto T., Decomposition and absorption of S-allyl-L-cysteine sulfoxide in the intestine and culture cells. Proceedings of the Annual Meeting of the Japanese Society Society for Bioscience, Biotechnology and Agrochemistry 2000. abstract 139
18. Augusti K. T., Sheela C. G., Antiperoxide effect of S-allyl cysteine sulfoxide, an insulin secretagogue, in diabetic rats. Experientia 1996 52 2 115 119 2-s2.0-9044251597 10.1007/BF01923354 (Pubitemid 26068502)
19. Colín-González A. L., Santana R. A., Silva-Islas C. A., Chánez-Cárdenas M. E., Santamaría A., Maldonado P. D., The antioxidant mechanisms underlying the aged garlic extract- and S-allylcysteine-induced protection. Oxidative Medicine and Cellular Longevity 2012 16 907162 10.1155/2012/907162
20. Poulos S. P., Dodson M. V., Hausman G. J., Cell line models for differentiation: preadipocytes and adipocytes. Experimental Biology and Medicine 2010 235 10 1185 1193 2-s2.0-77957836345 10.1258/ebm.2010.010063
21. Lin Y., Lee H., Berg A. H., Lisanti M. P., Shapiro L., Scherer P. E., The lipopolysaccharide-activated Toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. Journal of Biological Chemistry 2000 275 32 24255 24263 2-s2.0-0034637439 10.1074/jbc.M002137200 (Pubitemid 30626513)
22. Kopp A., Buechler C., Bala M., Toll-like receptor ligands cause proinflammatory and prodiabetic activation of adipocytes via phosphorylation of extracellular signal-regulated kinase and c-Jun N-terminal kinase but not interferon regulatory factor-3. Endocrinology 2010 151 1097 1108 10.1210/en.2009-1140
23. Creely S. J., McTernan P. G., Kusminski C. M., Fisher F. M., Da Silva N. F., Khanolkar M., Evans M., Harte A. L., Kumar S., Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. American Journal of Physiology-Endocrinology and Metabolism 2007 292 3 E740 E747 2-s2.0-33947182436 10.1152/ajpendo.00302.2006 (Pubitemid 46411051)
24. Garcia-Macedo R., Sanchez-Muñoz F., Almanza-Perez J. C., Duran-Reyes G., Alarcon-Aguilar F., Cruz M., Glycine increases mRNA adiponectin and diminishes pro-inflammatory adipokines expression in 3T3-L1 cells. European Journal of Pharmacology 2008 587 1-3 317 321 2-s2.0-44249094595 10.1016/j.ejphar.2008.03.051
25. Chakrabarti S. K., Cole B. K., Wen Y., Keller S. R., Nadler J. L., 12/15-Lipoxygenase products induce inflammation and impair insulin signaling in 3t3-l1 adipocytes. Obesity 2009 17 9 1657 1663 2-s2.0-69749102190 10.1038/oby.2009.192
26. An Y., Liu K., Zhou Y., Liu B., Salicylate inhibits macrophage-secreted factors induced adipocyte inflammation and changes of adipokines in 3T3-L1 adipocytes. Inflammation 2009 32 5 296 303 2-s2.0-70349696287 10.1007/s10753-009-9135-1
27. Freise C., Erben U., Neuman U., Kim K., Zeitz M., Somasundaram R., Ruehl M., An active extract of Lindera obtusiloba inhibits adipogenesis via sustained Wnt signaling and exerts anti-inflammatory effects in the 3T3-L1 preadipocytes. Journal of Nutritional Biochemistry 2010 21 12 1170 1177 2-s2.0-78249235641 10.1016/j.jnutbio.2009.09.013
28. Rojas-Mayorquín A. E., Torres-Ruíz N. M., Ortuño-Sahagún D., Gudiño-Cabrera G., Microarray analysis of striatal embryonic stem cells induced to differentiate by ensheathing cell conditioned media. Developmental Dynamics 2008 237 4 979 994 2-s2.0-42149083342 10.1002/dvdy.21489 (Pubitemid 351542295)
29. Ortuño-Sahagún D., Rivera-Cervantes M. C., Gudiño-Cabrera G., Junyent F., Verdaguer E., Auladell C., Pallàs M., Camins A., Beas-Zárate C., Microarray analysis of rat hippocampus exposed to excitotoxicity: reversal Na+/Ca2+ exchanger NCX3 is overexpressed in glial cells. Hippocampus 2012 22 2 128 140 2-s2.0-84856084138 10.1002/hipo.20869
30. Rodríguez-Calvo R., Serrano L., Coll T., Moullan N., Sánchez R. M., Merlos M., Palomer X., Laguna J. C., Michalik L., Wahli W., Vázquez-Carrera M., Activation of peroxisome proliferator-activated receptor β / δ inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor- B activity via extracellular signal-related kinase 1/2. Diabetes 2008 57 8 2149 2157 2-s2.0-50949105881 10.2337/db08-0176
31. Xu H., Barnes G. T., Yang Q., Tan G., Yang D., Chou C. J., Sole J., Nichols A., Ross J. S., Tartaglia L. A., Chen H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 2003 112 12 1821 1830 2-s2.0-9144223683 10.1172/JCI200319451 (Pubitemid 38063705)
32. Shen N., Yu X., Pan F. Y., Gao X., Xue B., Li C. J., An early response transcription factor, Egr-1, enhances insulin resistance in type 2 diabetes with chronic hyperinsulinism. Journal of Biological Chemistry 2011 286 16 14508 14515 2-s2.0-79954595062 10.1074/jbc.M110.190165
33. Robinson K., Prins J., Venkatesh B., Clinical review: adiponectin biology and its role in inflammation and critical illness. Critical Care 2011 15 1 9
34. Huang D. W., Sherman B. T., Lempicki R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 2009 4 1 44 57 2-s2.0-61449172037 10.1038/nprot.2008.211
35. Ortuño Sahagún D., Márquez-Aguirre A. L., Quintero-Fabián S., López-Roa R. I., Rojas-Mayorquín A. E., Modulation of PPAR- γ by nutraceutics as complementary treatment for obesity-related disorders and inflammatory diseases. PPAR Research 2012 2012 17 10.1155/2012/318613 318613
36. Ajuwon K. M., Banz W., Winters T. A., Stimulation with Peptidoglycan induces interleukin 6 and TLR2 expression and a concomitant downregulation of expression of adiponectin receptors 1 and 2 in 3T3-L1 adipocytes. Journal of Inflammation 2009 6 article 8 2-s2.0-65349188130 10.1186/1476-9255-6-8
37. Zoico E., Di Francesco V., Olioso D., Fratta Pasini A. M., Sepe A., Bosello O., Cinti S., Cominacini L., Zamboni M., In vitro aging of 3T3-L1 mouse adipocytes leads to altered metabolism and response to inflammation. Biogerontology 2010 11 1 111 122 2-s2.0-73449114975 10.1007/s10522-009-9236-0
38. Frost R. A., Nystrom G. J., Lang C. H., Lipopolysaccharide and proinflammatory cytokines stimulate interleukin-6 expression in C2C12 myoblasts: role of the Jun NH2-terminal kinase. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2003 285 5 R1153 R1164 2-s2.0-0142031629 (Pubitemid 37296368)
39. Ajuwon K. M., Jacobi S. K., Kuske J. L., Spurlock M. E., Interleukin-6 and interleukin-15 are selectively regulated by lipopolysaccharide and interferon- γ in primary pig adipocytes. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2004 286 3 R547 R553 2-s2.0-1342267442 (Pubitemid 38252620)
40. Zu L., He J., Jiang H., Xu C., Pu S., Xu G., Bacterial endotoxin stimulates adipose lipolysis via toll-like receptor 4 and extracellular signal-regulated kinase pathway. Journal of Biological Chemistry 2009 284 9 5915 5926 2-s2.0-65549131061 10.1074/jbc.M807852200
41. Poltorak A., He X., Smirnova I., Liu M. Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B., Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998 282 5396 2085 2088 2-s2.0-0032509295 10.1126/science.282.5396.2085 (Pubitemid 29001265)
42. Song M. J., Kim K. H., Yoon J. M., Kim J. B., Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochemical and Biophysical Research Communications 2006 346 3 739 745 2-s2.0-33745187112 10.1016/j.bbrc.2006.05.170
43. Suganami T., Tanimoto-Koyama K., Nishida J., Itoh M., Yuan X., Mizuarai S., Kotani H., Yamaoka S., Miyake K., Aoe S., Kamei Y., Ogawa Y., Role of the Toll-like receptor 4/NF- B pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 1 84 91 2-s2.0-33846323706 10.1161/01.ATV.0000251608.09329.9a (Pubitemid 46370478)
44. Chung S., LaPoint K., Martinez K., Kennedy A., Sandberg M. B., McIntosh M. K., Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 2006 147 11 5340 5351 2-s2.0-33751235259 10.1210/en.2006-0536 (Pubitemid 44790589)
45. Davis J. E., Gabler N. K., Walker-Daniels J., Spurlock M. E., The c-Jun N-terminal kinase mediates the induction of oxidative stress and insulin resistance by palmitate and toll-like receptor 2 and 4 ligands in 3T3-L1 adipocytes. Hormone and Metabolic Research 2009 41 7 523 530 2-s2.0-70149104677 10.1055/s-0029-1202852
46. Ajuwon K. M., Spurlock M. E., Adiponectin inhibits LPS-induced NF- B activation and IL-6 production and increases PPAR γ 2 expression in adipocytes. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2005 288 5 R1220 R1225 2-s2.0-17844396206 10.1152/ajpregu.00397.2004 (Pubitemid 40593705)
47. Zoico E., Garbin U., Olioso D., Mazzali G., Pasini A. M. F., Di Francesco V., Sepe A., Cominacini L., Zamboni M., The effects of adiponectin on interleukin-6 and MCP-1 secretion in lipopolysaccharide-treated 3T3-L1 adipocytes: role of the NF- B pathway. International Journal of Molecular Medicine 2009 24 6 847 851 2-s2.0-70350787404 10.3892/ijmm-00000302
48. Gómez-Arbeláez D., Lahera V., Oubiña P., Garlic extract improves adiponectin levels in subjects with metabolic syndrome: a double-blind, placebo-controlled, randomized, crossover study. Mediators of Inflammation 2013 2013 6 285795 10.1155/2013/285795
49. Yamashita A., Soga Y., Iwamoto Y., Asano T., Li Y., Abiko Y., Nishimura F., DNA microarray analyses of genes expressed differentially in 3T3-L1 adipocytes co-cultured with murine macrophage cell line RAW264.7 in the presence of the toll-like receptor 4 ligand bacterial endotoxin. International Journal of Obesity 2008 32 11 1725 1729 2-s2.0-56549101792 10.1038/ijo.2008.153
50. Papatriantafyllou M., Immunometabolism: CD4(+) T cell activation by adipocytes in obesity. Nature Reviews Immunology 2013 13 4, article 223 10.1038/nri3437
51. Palming J., Gabrielsson B. G., Jennische E., Smith U., Carlsson B., Carlsson L. M. S., Lönn M., Plasma cells and Fc receptors in human adipose tissue-lipogenic and anti-inflammatory effects of immunoglobulins on adipocytes. Biochemical and Biophysical Research Communications 2006 343 1 43 48 2-s2.0-33645100811 10.1016/j.bbrc.2006.02.114
52. Lee H. K., Lee B. H., Park S. A., Kim C. W., The proteomic analysis of an adipocyte differentiated from human mesenchymal stem cells using two-dimensional gel electrophoresis. Proteomics 2006 6 4 1223 1229 2-s2.0-33644543057 10.1002/pmic.200500385
53. Konno K., Wakabayashi Y., Akashi-Takamura S., Ishii T., Kobayashi M., Takahashi K., Kusumoto Y., Saitoh S. I., Yoshizawa Y., Miyake K., A molecule that is associated with Toll-like receptor 4 and regulates its cell surface expression. Biochemical and Biophysical Research Communications 2006 339 4 1076 1082 2-s2.0-29044448973 10.1016/j.bbrc.2005.11.123 (Pubitemid 41790574)
54. Hart B. E., Tapping R. I., Cell surface trafficking of TLR1 is differentially regulated by the chaperones PRAT4A and PRAT4B. Journal of Biological Chemistry 2012 287 16550 16562 10.1074/jbc.M112.342717
55. Rylova S. N., Albertioni F., Flygh G., Eriksson S., Activity profiles of deoxynucleoside kinases and 5′-nucleotidases in cultured adipocytes and myoblastic cells: insights into mitochondrial toxicity of nucleoside analogs. Biochemical Pharmacology 2005 69 6 951 960 2-s2.0-14644392828 10.1016/j.bcp.2004.12.010 (Pubitemid 40312712)
56. Ma X., Ding W., Wang J., Wu G., Zhang H., Yin J., Zhou L., Li D., LOC66273 isoform 2, a novel protein highly expressed in white adipose tissue, induces adipogenesis in 3T3-L1 cells. Journal of Nutrition 2012 142 3 448 455 2-s2.0-84858231181 10.3945/jn.111.152108
57. Gerin I., Bommer G. T., Lidell M. E., Cederberg A., Enerback S., McDougald O. A., On the role of FOX transcription factors in adipocyte differentiation and insulin-stimulated glucose uptake. Journal of Biological Chemistry 2009 284 16 10755 10763 2-s2.0-67449093355 10.1074/jbc.M809115200